Ruige Pharmaceutical Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Shanghai China

Primary Industry

Pharmaceuticals

About

Established in 2018 and based in Shanghai, China, Ruige Pharmaceutical is a medical company that focuses on the research and development of drugs in the field of tumors, autoimmunity and metabolism. The company engages in the research and development of drugs. It has a CARD technology platform that combines structural biology, computational chemistry, medicinal chemistry and biology. The CARD technology platform provides drug research and development services.

Current Investors

Qilu Pharmaceuical, Lilly Asia Ventures, Vertex Ventures China

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.regor.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

Key Contacts

Name	Position	Start Date	End Date	Vcard	Bio
	Chief Executive Officer & General Manager						BM

BM Board Member

Name	Firm	Deal Date	Number Of Deals	Vcard
						AI LP
						AI LP

AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.